Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03702842 · ClinicalTrials.gov registry record · NA

Stimulation to Enhance Walking Post-SCI

A NA study of SCI - Spinal Cord Injury and Incomplete Spinal Cord Injury, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
8
Enrollment target
1
Study location

NCT03702842 is a NA study of SCI - Spinal Cord Injury and Incomplete Spinal Cord Injury that has completed, run by University of Florida. The registered enrollment target is 8 participants, below the 37-participant average among 13 other SCI - Spinal Cord Injury trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03702842, a NA study of SCI - Spinal Cord Injury and Incomplete Spinal Cord Injury, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
8 participants
Enrollment target
1
Study location

Study Summary

This pilot study will investigate the effects of transcutaneous direct current stimulation (tsDCS) on walking function in individuals with incomplete spinal cord injury. Following rehabilitation, individuals with ISCI often demonstrate improved walking function, but continue to have serious impairments that limit mobility, community participation and quality of life. Adjuvants to rehabilitation that increase spinal excitation during training may enhance its effectiveness. tsDCS is a non-invasive neuromodulation approach that uses a mild electrical current, applied over the skin of the low back, to alter the membrane potential of spinal neurons. tsDCS will be applied during locomotor training, a well-established rehabilitation strategy that promotes walking recovery. Locomotor training emphasizes repetitive and task-specific practice of coordinated walking, often with therapist assistance or cueing to promote high quality movement patterns. The study team will explore if tsDCS combined with locomotor training increases spinal excitation and thereby improves the effectiveness of walking rehabilitation.

Interventions

  • DEVICE Soterix Medical tsDCS stimulator
  • OTHER Locomotor training

Study Locations (1)

Florida

  • Brooks Rehabilitation Hospital - Jacksonville

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2019-04-01
Est. Completion 2022-09-05
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT03702842

The ClinicalTrials.gov registry entry for NCT03702842 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 37-participant average among 13 other SCI - Spinal Cord Injury trials with a reported enrollment target (78% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with SCI - Spinal Cord Injury appearing as the primary indexed condition, and to 2 interventions - of which Soterix Medical tsDCS stimulator is the first listed.

NCT03702842 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT03702842 about?

NCT03702842 is a clinical study titled "Stimulation to Enhance Walking Post-SCI". This pilot study will investigate the effects of transcutaneous direct current stimulation (tsDCS) on walking function in individuals with incomplete spinal cord injury. Following rehabilitation, individuals with ISCI often demonstrate improved walking function, but continue to have serious impairme...

What is the current status of trial NCT03702842?

This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2019-04-01. Estimated completion is 2022-09-05.

What conditions does trial NCT03702842 study?

This clinical trial studies the following conditions: SCI - Spinal Cord Injury, Incomplete Spinal Cord Injury.

What interventions are being tested in trial NCT03702842?

The interventions under investigation include: Soterix Medical tsDCS stimulator (DEVICE), Locomotor training (OTHER).

Who is sponsoring clinical trial NCT03702842?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03702842 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for SCI - Spinal Cord Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.